Incyte Corp (INCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | INCY | ILMN | GMAB | ||
| Company | Incyte Corp | Illumina Inc | Genmab A/S ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 96.95 | 131.82 | 28.98 | ||
| High | 97.53 | 132.82 | 29.08 | ||
| Low | 94.56 | 128.31 | 28.15 | ||
| Latest | 95.32 | 132.72 | 28.30 | ||
| Change | -1.78 | +0.46 | -1.00 | ||
| % Change | -1.83% | +0.35% | -3.41% | ||
| Volume | 1,616,800 | 1,325,500 | 1,240,200 | ||
| 20-Day Average Volume | 1,491,000 | 1,402,180 | 1,641,620 | ||
| Previous Close | 97.10 | 132.26 | 29.30 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 93.87 | 125.80 | 27.14 | ||
| 20-Day Raw Stochastic | 56.89% | 96.09% | 74.78% | ||
| 20-Day Relative Strength | 48.78 | 56.61 | 51.48 | ||
| Weighted Alpha | +48.58 | +67.62 | +30.35 | ||
| Today's Opinion | Hold | 72% Buy | 40% Sell | ||
| Previous Opinion | 16% Buy | 72% Buy | 24% Sell | ||
| Last Month's Opinion | 8% Sell | 8% Buy | 40% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.69% since 04/09/26 | +7.32% since 04/09/26 | +0.07% since 04/09/26 | ||
| Low | 93.84 on 04/13/26 | 118.30 on 04/10/26 | 28.01 on 04/13/26 | ||
| High | 99.92 on 04/15/26 | 133.37 on 04/15/26 | 29.43 on 04/14/26 | ||
| 1-Month | |||||
| %Chg | +2.49% since 03/16/26 | +11.27% since 03/16/26 | +6.55% since 03/16/26 | ||
| Low | 89.25 on 03/24/26 | 116.74 on 03/27/26 | 24.95 on 03/20/26 | ||
| High | 99.92 on 04/15/26 | 133.37 on 04/15/26 | 29.43 on 04/14/26 | ||
| 3-Month | |||||
| %Chg | -10.25% since 01/16/26 | -6.30% since 01/16/26 | -12.25% since 01/16/26 | ||
| Low | 89.25 on 03/24/26 | 112.65 on 02/12/26 | 24.95 on 03/20/26 | ||
| High | 109.48 on 02/09/26 | 155.53 on 01/22/26 | 34.68 on 01/27/26 | ||
| 6-Month | |||||
| %Chg | +9.17% since 10/16/25 | +38.38% since 10/16/25 | -13.59% since 10/16/25 | ||
| Low | 84.02 on 10/28/25 | 94.00 on 10/30/25 | 24.95 on 03/20/26 | ||
| High | 112.29 on 01/07/26 | 155.53 on 01/22/26 | 35.43 on 01/14/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 19,324,260 | 20,091,216 | 18,825,456 | ||
| Shares Outstanding, K | 199,014 | 151,907 | 642,507 | ||
| Annual Sales | 5,141,240,000 | 4,343,000,000 | 3,720,000,000 | ||
| Annual Net Income | 1,286,650,000 | 850,000,000 | 963,000,000 | ||
| Last Quarter Sales | 1,506,840,000 | 1,159,000,000 | 1,058,000,000 | ||
| Last Quarter Net Income | 299,280,000 | 334,000,000 | 31,000,000 | ||
| 60-Month Beta | 0.85 | 1.49 | 0.97 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.80 on 02/10/26 | 1.35 on 02/05/26 | 0.05 on 02/17/26 | ||
| Latest Earnings Date | 04/28/26 | 04/30/26 | 05/14/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 16.87 | 26.87 | 18.75 | ||